These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30126667)

  • 41. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
    Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program.
    Lewis KA; Stroebel BM; Zhang L; Aouizerat B; Mattis AN; Flowers E
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin for prevention of type 2 diabetes.
    Hess AM; Sullivan DL
    Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Observational study of the efficacy of prolonged-release metformin in people with prediabetes.
    Hostalek U; Zilahi Z
    Curr Med Res Opin; 2020 Mar; 36(3):397-401. PubMed ID: 31793818
    [No Abstract]   [Full Text] [Related]  

  • 47. Metformin use and diabetic pregnancy-has its time come?
    Hawthorne G
    Diabet Med; 2006 Mar; 23(3):223-7. PubMed ID: 16492202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin for pregnancy and beyond: the pros and cons.
    Newman C; Dunne FP
    Diabet Med; 2022 Mar; 39(3):e14700. PubMed ID: 34569082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Considering metformin as a second-line treatment for children and adolescents with prediabetes.
    Hosey CM; Halpin K; Yan Y
    J Pediatr Endocrinol Metab; 2022 Jun; 35(6):727-732. PubMed ID: 35503504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials.
    He K; Guo Q; Ge J; Li J; Li C; Jing Z
    J Clin Pharm Ther; 2022 Feb; 47(2):168-177. PubMed ID: 34363237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin in pregnancy to avert gestational diabetes in women at high risk: Meta-analysis of randomized controlled trials.
    Doi SAR; Furuya-Kanamori L; Toft E; Musa OAH; Islam N; Clark J; Thalib L
    Obes Rev; 2020 Jan; 21(1):e12964. PubMed ID: 31667980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (5) Prevention or delay of type 2 diabetes.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S31-2. PubMed ID: 25537704
    [No Abstract]   [Full Text] [Related]  

  • 53. Metformin and health outcomes: An umbrella review of systematic reviews with meta-analyses.
    Li X; Celotto S; Pizzol D; Gasevic D; Ji MM; Barnini T; Solmi M; Stubbs B; Smith L; López Sánchez GF; Pesolillo G; Yu Z; Tzoulaki I; Theodoratou E; Ioannidis JPA; Veronese N; Demurtas J
    Eur J Clin Invest; 2021 Jul; 51(7):e13536. PubMed ID: 33709434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2012 Apr; 35(4):731-7. PubMed ID: 22442396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of diabetes: a strategic approach for individual patients.
    Shin JA; Lee JH; Kim HS; Choi YH; Cho JH; Yoon KH
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():79-84. PubMed ID: 23280871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug therapy in prediabetes.
    Mukhopadhyay P; Chowdhury S
    J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.
    Chukir T; Mandel L; Tchang BG; Al-Mulla NA; Igel LI; Kumar RB; Waitman J; Aronne LJ; Shukla AP
    Obes Res Clin Pract; 2021; 15(1):64-68. PubMed ID: 33386253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.